Iopidine

Apraclonidine Hydrochloride, the active ingredient in Iopidine, is a alpha‑2 adrenergic agonist presented as a ophthalmic solution for ocular use. It lowers intraocular pressure in patients with ocular hypertension and various forms of glaucoma. By decreasing aqueous humor production and enhancing uveoscleral outflow, it helps preserve visual function and prevent optic nerve damage. The medication is indicated for reduction of intraocular pressure following ocular surgery and as adjunct therapy in open‑angle glaucoma. It is marketed in the European Union and meets stringent quality standards.

GNH USA supplies Iopidine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Apraclonidine is used to manage conditions that involve elevated intraocular pressure, a key factor in glaucoma and postoperative ocular care.

- Ocular hypertension: reduces intraocular pressure to prevent progression to glaucoma. - Open-angle glaucoma: lowers pressure as adjunctive therapy to control disease. - Post‑operative ocular pressure control: helps maintain target pressure after eye surgery.

Apraclonidine may cause ocular and systemic adverse reactions, which are categorized by frequency.

Common Side Effects: - Burning or stinging at the eye. - Conjunctival redness. - Transient blurred vision.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angioedema, anaphylaxis). - Persistent ocular inflammation. - Marked hypotension causing dizziness or fainting.

Use of Iopidine requires careful consideration of patient-specific factors and proper handling.

- Contraindication: avoid in patients with known hypersensitivity to apraclonidine or any component of the formulation. - Caution: monitor patients with cardiovascular disease or low blood pressure. - Use: limit to prescribed dosing frequency; excessive use may increase risk of ocular irritation. - Pregnancy: safety not established; weigh potential benefits against unknown risks. - Driving: advise patients that transient visual disturbances may affect tasks requiring clear vision. - Store at room temperature below 25°C: keep in original container, protect from light and moisture.

Apraclonidine may interact with other ocular or systemic agents, affecting its safety and efficacy.

Major Interactions (Avoid): - Concurrent use with other ocular alpha‑agonists may cause additive hypotensive effect. - Systemic antihypertensive agents may potentiate blood pressure lowering.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops may influence intraocular pressure control. - Topical anesthetics may increase ocular irritation when used together. - Non‑steroidal anti‑inflammatory eye drops could alter drug absorption.